Prognostic Factors of Survival After Radiotherapy for Lung Cancer-The Impact of Smoking Pack Years
- PMID: 35478154
- PMCID: PMC9087111
- DOI: 10.21873/invivo.12830
Prognostic Factors of Survival After Radiotherapy for Lung Cancer-The Impact of Smoking Pack Years
Abstract
Background/aim: The prognostic role of smoking pack years after thoracic irradiation for lung cancer needs further clarification, since previous studies showed conflicting results. Therefore, this study investigated potential prognostic factors for survival including pack years in 170 lung cancer patients receiving local radiotherapy.
Patients and methods: Twelve factors were retrospectively evaluated for survival including age, sex, tumor site, histology, primary tumor stage, nodal stage, distant metastasis, radiation dose, upfront surgery or systemic treatment, pulmonary function, and number of pack years.
Results: On univariate analyses, absence of distant metastasis (p=0.049), radiation dose >56 Gy (p=0.019), and ≤40 pack years (p=0.005) were significantly associated with better survival. In the multivariate analysis, number of pack years (hazard ratio 2.18, 95% confidence interval 1.25-3.82, p=0.006) maintained significance; distant metastasis (p=0.34) and radiation dose (p=0.16) were not significant.
Conclusion: Number of pack years was an independent predictor of survival after thoracic irradiation for lung cancer.
Keywords: Lung cancer; prognostic factors; smoking pack years; survival; thoracic irradiation.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
On behalf of all Authors, the corresponding Author states that there are no conflicts of interest related to this study.
Figures
References
-
- Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms, Lang- version 1.0, 2018, AWMF-Registernummer: 020/007OL. Available at: http://leitlinienprogramm-onkologie.de/Lungenkarzinom.98.0.html. [Last assessed on February 10, 2022]
-
- Fujiwara M, Doi H, Igeta M, Suzuki H, Kitajima K, Tanooka M, Ishida T, Wakayama T, Yokoi T, Kuribayashi K, Kijima T, Hashimoto M, Kondo N, Matsumoto S, Hasegawa S, Kamikonya N, Yamakado K. Radiation pneumonitis after volumetric modulated arc therapy for non-small cell lung cancer. Anticancer Res. 2021;41(11):5793–5802. doi: 10.21873/anticanres.15396. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical